Piekarz, Richard L.

Clinical Toxicities of Histone Deacetylase Inhibitors

Subramanian, S., Bates, S. E., Wright, J. J., Espinoza-Delgado, I., & Piekarz, R. L. (2010) · Pharmaceuticals

Histone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation

Cited by 386

Entinostat: a promising treatment option for patients with advanced breast cancer

Connolly, R. M., Rudek, M. A., & Piekarz, R. (2017) · Future Oncology

Histone Deacetylase Inhibitors ResearchAdvanced Breast Cancer Therapies

Cited by 148

E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group

Connolly, R. M., Zhao, F., Miller, K. D., Lee, M.-J., Piekarz, R. L., Smith, K. L., Brown-Glaberman, U. A., Winn, J. S., Faller, B. A., Onitilo, A. A., et al. (2021) · Journal of Clinical Oncology

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 125

Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies

Siddiqi, T., Frankel, P., Beumer, J. H., Kiesel, B. F., Christner, S., Ruel, C., Song, J. Y., Chen, R., Kelly, K. R., Ailawadhi, S., et al. (2020) · Leukemia & Lymphoma

Lymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research

Cited by 30